These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22807504)

  • 1. Novel monoclonal antibody recognizing triglyceride-rich oxidized LDLs associated with severe liver disease and small oxidized LDLs in normal subjects.
    Sakurai T; Ichikawa A; Furukawa H; Wada N; Nagasaka A; Takahashi Y; Fujikawa M; Ikuta A; Furumaki H; Shiga M; Shimizu C; Hui SP; Jin S; Takeda S; Fuda H; Nagasaka H; Kobayashi S; Chiba H
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):456-62. PubMed ID: 22807504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological detection of large oxidized lipoproteins in hypertriglyceridemic serum.
    Sakurai T; Wada N; Takahashi Y; Ichikawa A; Ikuta A; Furumaki H; Hui SP; Jin S; Takeda S; Fuda H; Fujikawa M; Shimizu C; Nagasaka H; Furukawa H; Kobayashi S; Chiba H
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):465-72. PubMed ID: 23858503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity.
    Noto D; Rizzo M; Barbagallo CM; Cefalù AB; Verde AL; Fayer F; Notarbartolo A; Averna MR
    Metabolism; 2006 Oct; 55(10):1308-16. PubMed ID: 16979400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasma.
    Nakajima T; Matsunaga T; Kawai S; Hokari S; Inoue I; Katayama S; Nagata A; Komoda T
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):309-15. PubMed ID: 15298743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum level of IgG autoantibodies against oxidized low density lipoproteins and lag-phase of serum oxidation in coronary heart disease--inverse correlation.
    Bakalova R; Zhelev Z; Goudev A; Ribarov S; Nachev C
    Gen Physiol Biophys; 1999 Mar; 18(1):87-97. PubMed ID: 10378123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody.
    Nakano T; Nagata A
    J Lab Clin Med; 2003 Jun; 141(6):378-84. PubMed ID: 12819635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxidized LDL in patients with coronary heart disease and normal subjects].
    Hasegawa A; Toshima S; Nakano A; Nagai R
    Nihon Rinsho; 1999 Dec; 57(12):2754-8. PubMed ID: 10638208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein oxidation and antioxidized LDL antibodies in peritoneal dialysis patients.
    Bellazzi R; Maggi E; Bellomo G; Finardi G; Gazo A; Nai M; Romanini D; Falaschi F; Frattoni A; Perani G
    Adv Perit Dial; 1993; 9():312-7. PubMed ID: 8105953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial changes in LDL phenotypes in patients with myocardial infarction.
    Koba S; Tsunoda F; Hirano T; Iso Y; Suzuki H; Geshi E; Katagiri T
    Eur J Clin Invest; 2005 Mar; 35(3):171-9. PubMed ID: 15733071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins.
    Yang CY; Raya JL; Chen HH; Chen CH; Abe Y; Pownall HJ; Taylor AA; Smith CV
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1083-90. PubMed ID: 12689919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP; Zhou X
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
    Radulescu L; Stancu C; Antohe F
    Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL.
    Nakajima T; Sakagishi Y; Katahira T; Nagata A; Kuwae T; Nakamura H; Inoue I; Takahashi K; Katayama S; Komoda T
    Biochem Biophys Res Commun; 1995 Dec; 217(2):407-11. PubMed ID: 7503715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene.
    Ling W; Lougheed M; Suzuki H; Buchan A; Kodama T; Steinbrecher UP
    J Clin Invest; 1997 Jul; 100(2):244-52. PubMed ID: 9218499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of modified low density lipoprotein subfractions by capillary isotachophoresis.
    Zorn U; Haug C; Celik E; Wennauer R; Schmid-Kotsas A; Bachem MG; Grünert A
    Electrophoresis; 2001 Apr; 22(6):1143-9. PubMed ID: 11358140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
    Li GX; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.
    Posadas-Romero C; Torres-Tamayo M; Zamora-González J; Aguilar-Herrera BE; Posadas-Sánchez R; Cardoso-Saldaña G; Ladrón de Guevara G; Solis-Vallejo E; El Hafidi M
    Arthritis Rheum; 2004 Jan; 50(1):160-5. PubMed ID: 14730612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.